• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

World Market for Clinical Nutrition Products: Forecasts to 2021 (Infant, Parenteral and Enteral Foods), 6th Edition, The

$995.00 – $1,990.00

Clear
SKU: KLI5296709 Category: Pharmaceuticals Market Research Pages: 316
  • Description
  • Table of Contents
  • Latest reports

Description

Sales for infant formulas have increased substantially in global markets. Additionally, an aging population and increased awareness of the relationship between health and nutrition is driving sales for formulas in most regions worldwide. Newly updated with base year data for 2014, Clinical Nutrition Products: A Worldwide Perspective is a Kalorama Information report that focuses on three primary segments of essential medical nutrition:

  • Infant Nutrition (Milk-based, Soy-based, Elemental, Follow-Up, Organic, Probiotic / Prebiotic, Premature, Newborn and Other Specialized Formulas)
  • Enteral Nutrition (Standard and Fiber-containing Elemental and Semi-elemental, Specialized for Chronically Ill Patients)
  • Parenteral Nutrition (indicated for a variety of disorders including Gastrointestinal Disease, Burns, Extensive Wounds, Cancer, AIDS)

Information is presented as a worldwide overview, with special emphasis on the U.S., Europe, Asia Pacific and other key markets. The market segments provide an overview, description of products on the market, recent business activities, market estimates and forecasts, and competitive analysis of leading providers. Revenues for each segment were generated using dollar and unit sales for each product. The report includes incidence of conditions that often require enteral or parenteral feeding, birth rates, over 65 population, and overall global population.

Coverage of Issues and Trends in Clinical Nutrition

Many of the issues impacting the clinical nutrition market focus on safety concerns. These have been at the forefront over the past decade with respect to infant formulas and end-of-life complications. The issues and trends that are currently impacting the clinical nutrition market include:

  • Wound Care Applications
  • Parenteral nutrition shortages
  • Consolidation in China
  • Breast milk debate
  • Reimbursement of nutrition products
  • Changing landscape of elderly care
  • Food programs
  • Nutrition and education
  • DHA and ARA additives
  • Counterfeit products
  • Recalled infant formulas
  • Acquisition, mergers and alliances
  • Enteral feeding pump suppliers and products

A Growing Market with Thriving Competition

A handful of companies, ranging from global nutritional manufacturers to leading pharmaceutical companies, dominate competition in the clinical nutrition market. The majority of competitive participation takes place in developed regions such as the United States, Western Europe, and Japan. Many companies, however, are expanding into less developed regions, intensifying competition in less-tapped markets. China, for example, is among the expanding competitive regions where companies continue to break into the growing demand for clinical nutrition in new world markets. Companies highlighted in this study include:

  • Abbott
  • Baxter
  • B Braun
  • Danone
  • Fresenius Kabi
  • Hospira
  • Mead Johnson
  • Nestle
  • Perrigo Company

For the purpose of this study, Kalorama Information conducted interviews with more than 40 key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to the revenue and market share data presented in this report. Specific interviews with nutrition company representatives included marketing directors, division managers, and product representatives.

The base year for data is 2014. Historical data is provided for the years 2007 through 2013, with forecast data provided for 2015 through 2021. Compound annual growth rates (CAGRs) are provided for the 2007-2014, 2014-2021 and 2007-2021 periods for each industry segment covered. Competitive analysis is provided for the year 2014. The forecasted market analysis for 2015-2021 was based on demographic trends, new developments, and global expansion. All market data pertains to the world market at the manufacturers’ level.

Table of Contents

ONE: EXECUTIVE SUMMARY

Introduction

Infant Nutrition

Enteral Nutrition

Parenteral Nutrition

Scope and Methodology

Size and Growth of the Market

Issues and Trends Affecting the Market

Leading Competitors

TWO: INTRODUCTION TO THE CLINICAL NUTRITION INDUSTRY

Introduction and History of Nutrition in the Clinical Setting

Defining Clinical Nutrition

Infant Nutrition

Enteral Nutrition

Parenteral Nutrition

Regulatory Environment

Environments for Clinical Nutrition

Hospital Settings

United States

International Hospital/Acute Care Facility Data

Hospital Length of Stay

Assisted Living, Hospice, Home Healthcare

Nursing Homes

Hospice and Home Care

Essential Nutrients

Carbohydrates

Proteins

Fats

Vitamins

Minerals

Demographics and Statistics

Worldwide Demographics

Cancer and Nutrition

Cardiovascular Disease and Nutrition

Diabetes and Nutrition

HIV/AIDS and Nutrition

Obesity and Nutrition

Countries by Obesity Level

Overweight vs. Obese

Summary of Diseases

THREE: INFANT NUTRITION

Overview

Current Birth Rate and Demographic Trends

Infant Nutrition Market Indicators

Future Trends in Global Births

Underweight Children

Breastfeeding Trends

Infant Formula Product Categories

Milk-based Formulas

Soy-based Formulas

Elemental Formulas

Follow-Up Formulas

Organic Infant Formula

Probiotic/Prebiotic Infant Formula

Premature Infant Formulas

Newborn Formulas

Other Specialized Formulas

Industry Developments

Recent Business Activities

New Product Launches

Market Size and Growth

Global Market Introduction

Sales by Product Type

Global Markets

Infant Nutrition Market: United States

Infant Nutrition Market: Europe

Infant Nutrition Market: Asia Pacific

Infant Nutrition Market: Rest of World

Competitive Analysis

FOUR: ENTERAL NUTRITION

Overview

Current Trends in Aging Populations

Enteral Nutrition Market Indicators

Future Trends in Aging

Product Categories

Industry Developments

Recent Business Activities

New Product Launches

Related Business Announcements

Abbott Exits Enteral Feeding Device Market

Market Size and Growth

Global Market Introduction

Sales by Product Type

Global Markets

Enteral Nutrition Market: United States

Enteral Nutrition Market: Europe

Enteral Nutrition Market: Asia Pacific

Enteral Nutrition Markets: Rest of World

Competitive Analysis

FIVE: PARENTERAL NUTRITION

Overview

Gastrointestinal Disease

Crohn’s Disease and Ulcerative Colitis

Diverticulitis

Epidemiology of Relevant Gastrointestinal Diseases

Cancer

Global Cancer Statistics

AIDS

Infection Rates

Current Trends in Aging Populations

Enteral Nutrition Market Indicators

Future Trends in Aging

Product Categories

Amino Acids

Dextrose

Fats

Nutritional Additives

Industry Developments

Recent Business Activities

New Product Launches

Market Size and Growth

Global Market Introduction

Sales by Product Type

Global Markets

Parenteral Nutrition Market: United States

Parenteral Nutrition Market: Europe

Parenteral Nutrition Market: Asia Pacific

Parenteral Nutrition Market: Rest of World

Competitive Analysis

SIX: TOTAL MARKET SIZE AND FORECAST

Total Market Size and Forecast

Global Market Overview

Sales by Broad Market Segment

Markets by Geographic Region

Competitor Summary

SEVEN: ISSUES AND TRENDS AFFECTING THE NUTRITION MARKET

Introduction

Wound Care Applications

Parenteral Nutrition Shortages

Consolidation in China

Infant Formulas or Breast Milk: A Controversial Topic

Breast Feeding Rates in the U.S.

Infant Milk Proteins and Diabetes

WHO

Manufacturer Marketing of Infant Formula

Reimbursement of Nutrition Products

Changing Landscape of Elderly Care

Food Programs

WIC

WIC Participant Income and Ethnicity

WIC Contracts

Other Programs for Infant Formula Reimbursement

Cost Containment

Nutrition and Education

The Registered Dietician

Dietician Statistics in the United States

DHA and ARA Additives

Infant Formula Scams

Infant Formula Coupon Fraud

Recalls for Infant Formulas

Industry Acquisitions, Mergers and Alliances

Enteral Feeding Pumps

Caesarea Medical Electronics

Covidien

Danone Nutricia

Fresenius Kabi

Moog, Inc.

Nestle Nutrition

EIGHT: CORPORATE PROFILES

Introduction

Abbott

Baxter

B Braun

Danone

Fresenius Kabi

Hospira

Mead Johnson Nutrition

Nestlé

Perrigo

APPENDIX: COMPANY DIRECTORY

LIST OF EXHIBITS

ONE: EXECUTIVE SUMMARY

Table 1-1

The Global Market for Clinical Nutrition 2007-2021

Figure 1-1

The Global Market for Clinical Nutrition 2007-2021

TWO: INTRODUCTION TO THE CLINICAL NUTRITION INDUSTRY

Table 2-1

Nutrient Requirements for Infant Formulas as Required by the FDA Infant Formula Act

Table 2-2

U.S. Registered Hospitals by Type, 2010 and 2012

Figure 2-1

Number of Hospitals in the US, 1975-2005, Estimated 2015

Table 2-3

Statistics for U.S. Hospitals, 2012

Table 2-4

Registered Hospitals and Acute Care Centers by Country

Figure 2-2

Registered Hospitals and Acute Care Centers by Country

Table 2-5

U.S. Hospital Length of Stay, Average by Age Group, 2011

Figure 2-3

U.S. Hospital Length of Stay, Average by Age Group, 2011

Table 2-6

Average International Length of Stay, by Country 2012

Figure 2-4

Average International Length of Stay, by Country, 2012

Table 2-7

Estimated Nursing Service Establishments and Care Centers by Country

Figure 2-5

Estimated Nursing Service Establishments and Care Centers by Country

Figure 2-6

Number of Nursing Homes (United States), 2000-2012

Table 2-8

U.S. Nursing Homes, Beds, Residents and Occupancy Rate, 2011

Figure 2-7

Growth in Hospice Programs in the United States, 1998-2011

Figure 2-8

Patients Served with Hospice Programs in the United States, 1998-2011

Table 2-9

Percentage of Hospice Admissions by Primary Diagnosis, 2005 -2011

Figure 2-9

Percentage of Hospice Admissions by Cancer and Non-Cancer Diagnosis,2005 -2011

Table 2-10

Essential Nutrients for Human Health

Table 2-11

Global Population Change, 2005–2050

Figure 2-10

Global Population Change, 2005–2050

Figure 2-11

Estimated and Projected World Cancer Incidence by Selected Types of Cancer,2010 and 2020

Table 2-12

Total Cancer Incidence by Gender and Country, 2010 Estimates

Figure 2-12

Cancer Incidence by Gender and Country, 2010 Estimates

Table 2-13

Summary of Strength of Evidence on Lifestyle Factors and Risk of Developing Cancer

Table 2-14

Summary of Strength of Evidence on Lifestyle Factors and Risk of Developing Cardiovascular Diseases

Table 2-15

Summary of Strength of Evidence on Lifestyle Factors and Risk of Developing Type 2 Diabetes

Table 2-16

Total Number of People Living with HIV/AIDS, Newly Infected Population and Deaths, 2012 by Region

Figure 2-13

The Role of Nutrition Education as HIV Infection Develops

Table 2-17

Percent of Population That Is Obese*, 2011

Figure 2-14

Percent of the Population That Is Obese*, 2011

Figure 2-15

2011 Obesity and Overweight Percentages, Global Population

Table 2-18

Summary of Strength of Evidence on Factors That Might Promote or Protect Against Weight Gain and Obesity

Table 2-19

Classification of Overweight in Adults According to BMI

Table 2-20

World Prevalence of Select Diseases and Conditions by Type, 2010-2012 Estimates

Figure 2-16

World Prevalence of Select Diseases and Conditions by Type, 2010-2012 Estimates

THREE: INFANT NUTRITION

Table 3-1

Composition of Breast Milk (early and mature range) and Select Infant Formulas

Table 3-2

Live Births and Birth Rates by Select Country, 2014 Estimates

Figure 3-1

Live Births by Select Country, 2014 Estimates

Figure 3-2

Births Rates by Select Country, 2014 Estimates

Figure 3-3

Children Under 5 Years by Select Country, 2014 Estimates

Figure 3-4

Global Patterns in Births by Year and Region 2007, 2014, 2021

Figure 3-5

Asia Pacific Region: Births by Year and Select Country 2007, 2014, 2021

Figure 3-6

Europe Region: Births by Year and Select Country 2007, 2014, 2021

Figure 3-7

Latin America Region: Births by Year and Select Country 2007, 2014, 2021

Figure 3-8

Northern America: Births by Year and Country 2007, 2014, 2021

Figure 3-9

ROW Region: Births by Year and Select Country 2007, 2014, 2021

Figure 3-10

Number of Children Under 5 Years Considered Underweight, by Select Country

Figure 3-11

Percentage of All Children Under 5 Years Considered Underweight, by Select Country

Figure 3-12

Percentage of Infants Exclusively Breastfed by Select Country Six Months and Younger

Figure 3-13

Organic Infant Formula Market Share

Table 3-3

Marketed Infant Formulas (Manufacturer, Product Types, and Product Lines)

Table 3-4

The Global Market for Infant Nutrition 2007-2014 Forecasted 2015-2021

Figure 3-14

The Global Market for Infant Nutrition 2007-2014 Forecasted 2015-2021

Table 3-5

The Global Market for Infant Nutrition by Product Type 2007-2014 Forecasted 2015-2021

Figure 3-15

The Global Market for Infant Nutrition by Product Type 2007-2014 Forecasted 2015-2021

Figure 3-16

The Global Market for Infant Nutrition, Distribution of Sales by Product Type 2014

Figure 3-17

The Global Market for Infant Nutrition by Region 2007-2014 Forecasted 2015-2021

Figure 3-18

The Global Market for Infant Nutrition Market Share by Select Country, 2014

Figure 3-19

The U.S. Infant Nutrition Market Size 2007-2014 Forecasted 2015-2021

Figure 3-20

The European Infant Nutrition Market Size 2007-2014 Forecasted 2015-2021

Figure 3-21

The European Infant Nutrition Market Size by Country 2007-2014

Figure 3-22

The Asia Pacific Infant Nutrition Market Size 2007-2014 Forecasted 2015-2021

Figure 3-23

The Asia Pacific Infant Nutrition Market Size by Country 2007-2014

Figure 3-24

The ROW Infant Nutrition Market Size 2007-2014 Forecasted 2015-2021

Table 3-6

The Global Market for Infant Nutrition Estimated Revenues and Market Share of Leading Suppliers 2014

Figure 3-25

The Global Market for Infant Nutrition Estimated Market Share by Leading Suppliers 2014

Table 3-7

The Global Market for Infant Nutrition Estimated Market Shares by Region for Leading Suppliers 2014

Figure 3-26

Estimated Infant Formula U.S. Market Shares for Leading Suppliers 2014

Figure 3-27

Estimated Infant Formula Market Shares Outside the U.S. for Leading Suppliers 2014

FOUR: ENTERAL NUTRITION

Table 4-1

Aging Population, Percent of Total Population, and Annual Growth by Select Country, 2014 Estimates

Figure 4-1

Over 65 Population by Select Country, 2014 Estimates

Figure 4-2

Over 65 Population as a Percent of Total Population by Select Country, 2014 Estimates

Figure 4-3

Over 65 Annual Population Growth by Select Country, 2014 Estimates

Figure 4-4

Global Patterns in Aging Populations by Year and Region 2007, 2014, 2021

Figure 4-5

Asia Pacific Region: Aging Populations by Year and Select Country 2007, 2014, 2021

Figure 4-6

Europe Region: Aging Populations by Year and Select Country 2007, 2014, 2021

Figure 4-7

Latin America Region: Aging Populations by Year and Select Country 2007, 2014, 2021

Figure 4-8

Northern America: Aging Populations by Year and Country 2007, 2014, 2021

Figure 4-9

ROW Region: Aging Populations by Year and Select Country 2007, 2014, 2021

Table 4-2

Marketed Pediatric and Adult Enteral Formulas (Manufacturer, Product Types, and Product Lines)

Table 4-3

The Global Market for Enteral Nutrition 2007-2014 Forecasted 2015-2021

Figure 4-10

The Global Market for Enteral Nutrition 2007-2014 Forecasted 2015-2021

Table 4-4

The Global Market for Enteral Nutrition by Product Type 2007-2014 Forecasted 2015-2021

Figure 4-11

The Global Market for Enteral Nutrition by Product Type 2007-2014 Forecasted 2015-2021

Figure 4-12

The Global Market for Enteral Nutrition, Distribution of Sales by Product Type 2014

Figure 4-13

The Global Market for Enteral Nutrition by Region 2007-2014 Forecasted 2015-2021

Figure 4-14

The Global Market for Enteral Nutrition Market Share by Select Country, 2014

Figure 4-15

The U.S. Enteral Nutrition Market Size 2007-2014 Forecasted 2015-2021

Figure 4-16

The European Enteral Nutrition Market Size 2007-2014 Forecasted 2015-2021

Figure 4-17

The European Enteral Nutrition Market Size by Country 2007-2014

Figure 4-18

The Asia Pacific Enteral Nutrition Market Size 2007-2014 Forecasted 2015-2021

Figure 4-19

The Asia Pacific Enteral Nutrition Market Size by Country 2007-2014

Figure 4-20

The ROW Enteral Nutrition Market Size 2007-2014 Forecasted 2015-2021

Table 4-5

The Global Market for Enteral Nutrition Estimated Revenues and Market Share of Leading Suppliers 2014

Figure 4-21

The Global Market for Enteral Nutrition Estimated Market Share by Leading Suppliers 2014

Table 4-6

The Global Market for Enteral Nutrition Estimated Market Shares by Region for Leading Suppliers 2014

Figure 4-22

Estimated Enteral Nutrition U.S. Market Shares for Leading Suppliers 2014

Figure 4-23

Estimated Enteral Nutrition Market Shares Outside the U.S. for Leading Suppliers 2014

FIVE: PARENTERAL NUTRITION

Table 5-1

Aging Population, Percent of Total Population, and Annual Growth by Select Country, 2014 Estimates

Figure 5-1

Over 65 Population by Select Country, 2014 Estimates

Figure 5-2

Over 65 Population as a Percent of Total Population by Select Country, 2014 Estimates

Figure 5-3

Over 65 Annual Population Growth by Select Country, 2014 Estimates

Figure 5-4

Global Patterns in Aging Populations by Year and Region 2007, 2014, 2021

Figure 5-5

Asia Pacific Region: Aging Populations by Year and Select Country 2007, 2014, 2021

Figure 5-6

Europe Region: Aging Populations by Year and Select Country 2007, 2014, 2021

Figure 5-7

Latin America Region: Aging Populations by Year and Select Country 2007, 2014, 2021

Figure 5-8

Northern America: Aging Populations by Year and Country 2007, 2014, 2021

Figure 5-9

ROW Region: Aging Populations by Year and Select Country 2007, 2014, 2021

Table 5-2

Standard Electrolyte Requirements

Table 5-3

Standard Parenteral Multivitamin Package* Vitamin

Table 5-4

Standard Parenteral Trace Elements Package

Table 5-5

Single Parenteral Trace Element Formulations

Table 5-6

Major Marketed Parenteral Formulas (Manufacturer, Product Types, and Product Lines)

Table 5-7

The Market for Parenteral Nutrition 2007-2014 Forecasted 2015-2021

Figure 5-10

The Global Market for Parenteral Nutrition 2007-2014 Forecasted 2015-2021

Table 5-8

The Global Market for Parenteral Nutrition by Product Type 2007-2014 Forecasted 2015-2021

Figure 5-11

The Global Market for Parenteral Nutrition by Product Type 2007-2014 Forecasted 2015-2021

Figure 5-12

The Global Market for Parenteral Nutrition, Distribution of Sales by Product Type 2014

Figure 5-13

The Global Market for Parenteral Nutrition by Region 2007-2014 Forecasted 2015-2021

Figure 5-14

The Global Market for Parenteral Nutrition Market Share by Select Country, 2014

Figure 5-15

The U.S. Parenteral Nutrition Market Size 2007-2014 Forecasted 2015-2021

Figure 5-16

The European Parenteral Nutrition Market Size 2007-2014 Forecasted 2015-2021

Figure 5-17

The European Parenteral Nutrition Market Size by Country 2007-2014

Figure 5-18

The Asia Pacific Parenteral Nutrition Market Size 2007-2014 Forecasted 2015-2021

Figure 5-19

The Asia Pacific Parenteral Nutrition Market Size by Country 2007-2014

Figure 5-20

The ROW Parenteral Nutrition Market Size 2007-2014 Forecasted 2015-2021

Table 5-9

The Global Market for Parenteral Nutrition Estimated Revenues and Market Share of Leading Suppliers 2014

Figure 5-21

The Global Market for Parenteral Nutrition Estimated Market Share by Leading Suppliers 2014

Table 5-10

The Global Market for Parenteral Nutrition Estimated Market Shares by Region for Leading Suppliers 2014

Figure 5-22

Estimated Parenteral Nutrition U.S. Market Shares for Leading Suppliers 2014

Figure 5-23

Estimated Parenteral Nutrition Market Shares Outside the U.S. for Leading Suppliers 2014

SIX: TOTAL MARKET SIZE AND FORECAST

Table 6-1

The Global Market for Clinical Nutrition 2007-2021

Figure 6-1

The Global Market for Clinical Nutrition 2007-2021

Table 6-2

The Global Market for Clinical Nutrition by Market Segment 2007-2014 Forecasted 2015-2021

Figure 6-2

The Global Market for Clinical Nutrition by Market Segment 2007-2021

Figure 6-3

The Global Market for Clinical Nutrition, Distribution of Sales by Market Segment 2014

Figure 6-4

The Global Market for Clinical Nutrition, Distribution of Sales by Market Segment 2021

Figure 6-5

The Global Market for Clinical Nutrition by Select Country 2007 and 2014

Table 6-3

Leading Suppliers’ Clinical Nutrition Revenues and Significant Segments of Participation, 2014

Figure 6-6

Leading Suppliers Clinical Nutrition Estimated Market Shares, 2014

SEVEN: ISSUES AND TRENDS AFFECTING THE NUTRITION MARKET

Table 7-1

Nutrition Products with Specific Wound Management Benefits

Table 7-2

2014 Total Parenteral Nutrition Shortages

Table 7-3

U.S. National Breastfeeding Trend

Figure 7-1

U.S. National Breastfeeding Trend

Table 7-4

Medicare Reimbursement for Home Parenteral and Enteral Nutrition; DME MAC

Table 7-5

Enteral Product Classification, 2012-2014

Table 7-6

Example of DMEPOS Fee Schedule for Common Enteral Items, 2014 Fee Schedule

Table 7-7

Example of DMEPOS Fee Schedule for Common Parenteral Items, 2014 Fee Schedule

Table 7-8

WIC Participants by Participant Category in 2006, and 2009-2012

Figure 7-2

Distribution of WIC Participants by Type, 2006

Figure 7-3

Distribution of WIC Participants by Type, 2012

Table 7- 9

WIC Eligibles, Participants, and Coverage Rates by State

Table 7-10

Dieticians and Nutritionists Facts 2012

Table 7-11

Recalls of Infant Feeding Products, 2001-2012

Table 7-12

Selected Enteral Feeding Pumps

 

    Cell and Gene Therapy Market Dynamics by Disease Type: Development, Trends, and Forecasts, 4th Edition (2024-2030)
    April 11, 2025
    Cell and Gene Therapy Market Deals: Investment, M&A, and Partnerships, 2021-2025 (3rd Edition)
    February 13, 2025
    Cell and Gene Therapy Deals Analysis, 2021-2024
    June 3, 2024
    Cell Therapy and Gene Therapy Markets (Markets by Disease Type), 2023-2029
    April 30, 2024

Related products

  • Placeholder image

    Cardiovascular Disease: The 45 Market in the United States for Drugs and Medical Devices

    $2,995.00 – $5,990.00
  • Placeholder image

    Market for Rx-to-OTC Switches, 3rd Edition, The

    $2,625.00 – $5,250.00
  • Placeholder image

    World Market for Anti-infectives Series: Volumes I – III – Antifungals, Antibacterials and Antivirals, The

    $6,000.00 – $12,000.00
  • Placeholder image

    World Market for Anti-infectives Volume II: The World Market for Antibacterial Medications, The

    $2,500.00 – $5,000.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Drugs of Abuse Testing Markets: Forecasts to 2018 (Lab-Based, Professional POC,...Companion Diagnostics Markets: Forecasts to 2018 (Cancer, Cardiovascular and...
Scroll to top